Neuromuscular Blocking Drug Global Market Report 2024

Global Neuromuscular Blocking Drug Market Report 2024

Neuromuscular Blocking Drug Global Market Report 2024 – By Type (Non-Polarizing Agents, Depolarizing Agents), By Application (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others Applications), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Name: Neuromuscular Blocking Drug Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Neuromuscular Blocking Drug Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : November 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Global Neuromuscular Blocking Drug Market Infographic

Proud Members Of

Neuromuscular Blocking Drug Market Definition

A neuromuscular blocking drug is a medication that interrupts the transmission of nerve impulses to muscles, leading to temporary paralysis of skeletal muscles. These drugs work by either blocking the action of acetylcholine (a neurotransmitter) at the neuromuscular junction, where nerves communicate with muscles, or by mimicking acetylcholine and overstimulating the muscle receptor, causing it to become unresponsive. Neuromuscular blocking drugs are primarily used in medical settings, particularly during surgeries or other medical procedures, to facilitate intubation (inserting a breathing tube) and ensure muscle relaxation.

The main types of neuromuscular blocking drugs are non-polarizing agents and depolarizing agents. Non-polarizing agents are neuromuscular blockers that work by competing with the neurotransmitter acetylcholine at the neuromuscular junction, preventing muscle contraction. These types of drugs can be applicable for hospital pharmacy, retail pharmacy, online pharmacy, and others and cater to various end users, including hospitals, homecare, specialty clinics, and others.

Neuromuscular Blocking Drug Market Segmentation

The neuromuscular blocking drug market covered in this report is segmented –

1) By Type: Non-Polarizing Agents, Depolarizing Agents

2) By Application: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others Applications

3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Global Neuromuscular Blocking Drug Market Size 2023 to 2028: Graph

Neuromuscular Blocking Drug Market Size 2024 And Growth Rate

The neuromuscular blocking drug market size has increased by grown strongly in recent years. It will grow from $3.68 billion in 2023 to $3.87 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increased prevalence of conditions, increased awareness and training, increased healthcare spending, improved drug reversibility, and rise emphasis on patient safety.

Neuromuscular Blocking Drug Market Growth Forecast

The neuromuscular blocking drug market size is expected to see strong growth in the next few years. It will grow to $4.75 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to regulatory approvals, growth in outpatient and day surgeries, the expansion of medical tourism and strategic alliances, the growing prevalence of musculoskeletal disorders, and the increasing prevalence of surgical procedures. Major trends in the forecast period include the development of non-sedative formulations, the development of new NMBDs, advances in personalized medicine, the development of combination therapies, and patient-centric drug development.

Book your 30 minutes free consultation with our research experts

Neuromuscular Blocking Drug Market Driver: Increasing Prevalence Of Surgical Procedures Is Driving The Growth Of The Neuromuscular Blocking Drug Market

The increasing number of surgical procedures is expected to propel the growth of the neuromuscular blocking drug market going forward. Surgical procedures are medical operations involving incisions, excisions, or other techniques to treat injuries, diseases, or conditions. The increasing number of surgical procedures is due to improved diagnostic tools, greater access to healthcare, a focus on the quality of life, and rising patient awareness and expectations. Neuromuscular blocking drugs are used in surgical procedures to induce muscle relaxation and facilitate various aspects of the operation. For instance, in September 2023, according to a report published by the American Society of Plastic Surgeons, a US-based professional society, in 2022, a total of 26.2 million surgical and minimally invasive cosmetic and reconstructive procedures were carried out in the United States. Therefore, the increasing prevalence of surgical procedures drives the growth of the neuromuscular blocking drug market.

Global Neuromuscular Blocking Drug Market Major Players

Major companies operating in the neuromuscular blocking drug market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Bayer AG, Fresenius Kabi AG, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Limited, Baxter International Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, UCB Pharma S.A., Eisai Co Ltd., Ipsen S.A., B. Braun Melsungen AG, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Mallinckrodt Pharmaceuticals plc, Mylan N.V., Nippon Shinyaku Co Ltd., Sagent Pharmaceuticals Inc., Osmosis Inc., Cadila Healthcare Limited

Global Neuromuscular Blocking Drug Market Trend: Advancements In Neuromuscular Blocking Drug Enhanced Market Growth

Major companies operating in the neuromuscular blocking drug market focus on broadening their product offerings through strategic collaborations to expand their market reach and drive innovation in drug formulations and delivery methods. Strategic collaborations involve partnerships between companies to share resources and expertise, enhancing product development and market reach. For instance, in May 2022, BDR Pharma, an India-based pharmaceutical company, partnered with Varenyam Healthcare, an India-based certified pharmaceutical manufacturing company, to launch Sugmadex, a pioneering anesthesia drug that offers safe, rapid, and complete reversal of shallow, moderate, and deep neuromuscular block (NMB), effectively removing the anesthesia effect on the body. Unlike existing agents, Sugmadex effectively addresses profound NMB and reduces post-operative respiratory complications. Available in 2 ml and 5 ml single-dose vials, Sugmadex promises enhanced efficiency and patient safety, improving recovery rates.

Neuromuscular Blocking Drug Market Merger And Acquisition: Biogen Acquires Reata Pharmaceuticals To Strengthen Rare Disease Portfolio

In September 2023, Biogen Inc., a US-based biotechnology company, acquired Reata Pharmaceuticals for an undisclosed amount. Through this acquisition, Biogen aims to enhance its rare disease portfolio by integrating the FDA-approved SKYCLARYS (omaveloxolone) for Friedreich's ataxia and complementing its existing treatments for spinal muscular atrophy and amyotrophic lateral sclerosis to address unmet medical needs and drive growth. Reata Pharmaceuticals is a US-based pharmaceutical company that offers rare neuromuscular blocking drugs.

Regional Insights For The Global Neuromuscular Blocking Drug Market

North America was the largest region in the neuromuscular blocking drug market in 2023. The regions covered in the neuromuscular blocking drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neuromuscular blocking drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuromuscular blocking drug market consists of sales of ganta curium, rapacuronium, alcuronium, tubocurarine, and metocurine. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The neuromuscular blocking drugs market research report is one of a series of new reports from The Business Research Company that provides neuromuscular blocking drugs market statistics, including neuromuscular blocking drugs industry global market size, regional shares, competitors with a neuromuscular blocking drugs market share, detailed neuromuscular blocking drugs market segments, market trends and opportunities, and any further data you may need to thrive in the neuromuscular blocking drugs industry. This neuromuscular blocking drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Neuromuscular Blocking Drug Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2024	$ 15.69 Billion
Revenue Forecast In 2033	$ 20.05 Billion
Growth Rate	CAGR of 6.30% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Type: Non-Polarizing Agents, Depolarizing Agents 2) By Application: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others Applications 3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Merck & Co Inc., AbbVie Inc., Bayer AG, Fresenius Kabi AG, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Limited, Baxter International Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, UCB Pharma S.A., Eisai Co Ltd., Ipsen S.A., B. Braun Melsungen AG, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Mallinckrodt Pharmaceuticals plc, Mylan N.V., Nippon Shinyaku Co Ltd., Sagent Pharmaceuticals Inc., Osmosis Inc., Cadila Healthcare Limited
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Neuromuscular Blocking Drug Market Characteristics

3. Neuromuscular Blocking Drug Market Trends And Strategies

4. Neuromuscular Blocking Drug Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Neuromuscular Blocking Drug Market Size and Growth

5.1. Global Neuromuscular Blocking Drug Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Neuromuscular Blocking Drug Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Neuromuscular Blocking Drug Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Neuromuscular Blocking Drug Market Segmentation

6.1. Global Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Non-Polarizing Agents

Depolarizing Agents

6.2. Global Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Others Applications

6.3. Global Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End-Users

7. Neuromuscular Blocking Drug Market Regional And Country Analysis

7.1. Global Neuromuscular Blocking Drug Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Neuromuscular Blocking Drug Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Neuromuscular Blocking Drug Market

8.1. Asia-Pacific Neuromuscular Blocking Drug Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Neuromuscular Blocking Drug Market

9.1. China Neuromuscular Blocking Drug Market Overview

9.2. China Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Neuromuscular Blocking Drug Market

10.1. India Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Neuromuscular Blocking Drug Market

11.1. Japan Neuromuscular Blocking Drug Market Overview

11.2. Japan Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Neuromuscular Blocking Drug Market

12.1. Australia Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Neuromuscular Blocking Drug Market

13.1. Indonesia Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Neuromuscular Blocking Drug Market

14.1. South Korea Neuromuscular Blocking Drug Market Overview

14.2. South Korea Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Neuromuscular Blocking Drug Market

15.1. Western Europe Neuromuscular Blocking Drug Market Overview

15.2. Western Europe Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Neuromuscular Blocking Drug Market

16.1. UK Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Neuromuscular Blocking Drug Market

17.1. Germany Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Neuromuscular Blocking Drug Market

18.1. France Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Neuromuscular Blocking Drug Market

19.1. Italy Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Neuromuscular Blocking Drug Market

20.1. Spain Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Neuromuscular Blocking Drug Market

21.1. Eastern Europe Neuromuscular Blocking Drug Market Overview

21.2. Eastern Europe Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Neuromuscular Blocking Drug Market

22.1. Russia Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Neuromuscular Blocking Drug Market

23.1. North America Neuromuscular Blocking Drug Market Overview

23.2. North America Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Neuromuscular Blocking Drug Market

24.1. USA Neuromuscular Blocking Drug Market Overview

24.2. USA Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Neuromuscular Blocking Drug Market

25.1. Canada Neuromuscular Blocking Drug Market Overview

25.2. Canada Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Neuromuscular Blocking Drug Market

26.1. South America Neuromuscular Blocking Drug Market Overview

26.2. South America Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Neuromuscular Blocking Drug Market

27.1. Brazil Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Neuromuscular Blocking Drug Market

28.1. Middle East Neuromuscular Blocking Drug Market Overview

28.2. Middle East Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Neuromuscular Blocking Drug Market

29.1. Africa Neuromuscular Blocking Drug Market Overview

29.2. Africa Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Neuromuscular Blocking Drug Market Competitive Landscape And Company Profiles

30.1. Neuromuscular Blocking Drug Market Competitive Landscape

30.2. Neuromuscular Blocking Drug Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Merck & Co Inc.

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. AbbVie Inc.

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Bayer AG

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Fresenius Kabi AG

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Neuromuscular Blocking Drug Market Other Major And Innovative Companies

31.1. AstraZeneca PLC

31.2. Novartis AG

31.3. GlaxoSmithKline plc

31.4. Boehringer Ingelheim GmbH

31.5. Teva Pharmaceutical Industries Limited

31.6. Baxter International Inc.

31.7. Astellas Pharma Inc.

31.8. Daiichi Sankyo Company Limited

31.9. UCB Pharma S.A.

31.10. Eisai Co Ltd.

31.11. Ipsen S.A.

31.12. B. Braun Melsungen AG

31.13. Aurobindo Pharma Limited

31.14. Hikma Pharmaceuticals PLC

31.15. Mallinckrodt Pharmaceuticals plc

32. Global Neuromuscular Blocking Drug Market Competitive Benchmarking

33. Global Neuromuscular Blocking Drug Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Neuromuscular Blocking Drug Market

35. Neuromuscular Blocking Drug Market Future Outlook and Potential Analysis

35.1 Neuromuscular Blocking Drug Market In 2028 - Countries Offering Most New Opportunities

35.2 Neuromuscular Blocking Drug Market In 2028 - Segments Offering Most New Opportunities

35.3 Neuromuscular Blocking Drug Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Figure 1:

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Figure 3: Global Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 4: Global Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 5: Global Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 6: Global Neuromuscular Blocking Drug Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 7: Global Neuromuscular Blocking Drug Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 8: Asia-Pacific, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 9: Asia-Pacific, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 10: Asia-Pacific, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 11: China, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 12: China, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 13: China, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 14: India, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 15: India, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 16: India, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 17: Japan, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 18: Japan, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 19: Japan, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 20: Australia, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 21: Australia, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 22: Australia, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 23: Indonesia, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 24: Indonesia, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 25: Indonesia, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 26: South Korea, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 27: South Korea, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 28: South Korea, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 29: Western Europe, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 30: Western Europe, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 31: Western Europe, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 32: UK, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 33: UK, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 34: UK, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 35: Germany, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 36: Germany, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 37: Germany, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 38: France, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 39: France, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 40: France, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 41: Italy, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 42: Italy, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 43: Italy, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 44: Spain, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 45: Spain, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 46: Spain, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 47: Eastern Europe, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 48: Eastern Europe, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 49: Eastern Europe, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 50: Russia, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 51: Russia, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 52: Russia, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 53: North America, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 54: North America, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 55: North America, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 56: USA, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 57: USA, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 58: USA, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 59: Canada, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 60: Canada, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 61: Canada, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 62: South America, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 63: South America, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 64: South America, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 65: Brazil, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 66: Brazil, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 67: Brazil, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 68: Middle East, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 69: Middle East, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 70: Middle East, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 71: Africa, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 72: Africa, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 73: Africa, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 74: Pfizer Inc. Financial Performance
Figure 75: Merck & Co Inc. Financial Performance
Figure 76: AbbVie Inc. Financial Performance
Figure 77: Bayer AG Financial Performance
Figure 78: Fresenius Kabi AG Financial Performance

List Of Figures

Table 1:

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 6: Global Neuromuscular Blocking Drug Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 7: Global Neuromuscular Blocking Drug Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 8: Asia-Pacific, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 9: Asia-Pacific, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 10: Asia-Pacific, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 11: China, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 12: China, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 13: China, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 14: India, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 15: India, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 16: India, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 17: Japan, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 18: Japan, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 19: Japan, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 20: Australia, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 21: Australia, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 22: Australia, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 23: Indonesia, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 24: Indonesia, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 25: Indonesia, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 26: South Korea, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 27: South Korea, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 28: South Korea, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 29: Western Europe, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 30: Western Europe, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 31: Western Europe, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 32: UK, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 33: UK, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 34: UK, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 35: Germany, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 36: Germany, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 37: Germany, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 38: France, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 39: France, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 40: France, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 41: Italy, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 42: Italy, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 43: Italy, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 44: Spain, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 45: Spain, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 46: Spain, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 47: Eastern Europe, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 48: Eastern Europe, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 49: Eastern Europe, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 50: Russia, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 51: Russia, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 52: Russia, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 53: North America, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 54: North America, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 55: North America, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 56: USA, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 57: USA, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 58: USA, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 59: Canada, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 60: Canada, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 61: Canada, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 62: South America, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 63: South America, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 64: South America, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 65: Brazil, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 66: Brazil, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 67: Brazil, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 68: Middle East, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 69: Middle East, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 70: Middle East, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 71: Africa, Neuromuscular Blocking Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 72: Africa, Neuromuscular Blocking Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 73: Africa, Neuromuscular Blocking Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 74: Pfizer Inc. Financial Performance
Table 75: Merck & Co Inc. Financial Performance
Table 76: AbbVie Inc. Financial Performance
Table 77: Bayer AG Financial Performance
Table 78: Fresenius Kabi AG Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Global Protein Purification And Isolation Market 2022 – Market Opportunities And Strategies

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the stem cell therapy market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the regenerative medicine for cartilage market research report 2022 with industry size, share, segments and market growth

Neutropenia Biologic Drug Treatment Global Market Report 2024 – By Drug Type (Filgrastim, Pegfilgrastim, Lenograstim, Lipegfilgrastim, Sargramostim), By Treatment Type (Antibiotic Drugs, Granulocyte-Colony-Stimulating Factor (G-CSF), Antifungal Drugs, Other Treatment Types), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Anti-Parkinson Drugs Global Market Report 2024 – By Drugs Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs ), By Route of Administration (Oral, Injection, Transdermal ), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Acne Drugs Global Market Report 2024 – By Type (Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs), By Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Other Therapeutics), By End User (Hospitals & Clinics, Pharmacies & Drug Stores, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Sarcoma Drugs Global Market Report 2024 – By Treatment Type (Chemotherapy, Targeted Therapy), By Disease Indication (Malignant Bone Tumors, Soft Tissue Sarcomaz), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Drug Infusion Systems Global Market Report 2024 – By Product Type (Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System), By Route Of Administration (Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration), By Application (Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Nephrology Drugs Global Market Report 2024 – By Drugs (Antihypertensive Agents, Erythropoiesis-Stimulating Agents, Diuretics, ACE Inhibitors, Antidiabetic Agents, Other Drugs), By Route Of Administration (Oral, Parenteral, Other Route Of Administration), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Myelodysplastic Syndrome Drugs Global Market Report 2024 – By Therapeutic Class (Immunomodulatory Drugs, Hypomethylating Agents, Anti-anemics), By Type of Syndrome (Refractory Cytopenia With Multilineage Dysplasia, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Ringed Sideroblasts), By Route of Administration (Oral, Parenteral), By Applications (Original, Generics), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Drug Delivery Devices Global Market Report 2024 – By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the neuromuscular blocking drug market?

How will the neuromuscular blocking drug market drivers and restraints affect the neuromuscular blocking drug market dynamics? What forces will shape the neuromuscular blocking drug industry going forward?

The neuromuscular blocking drug market major growth driver - Increasing Prevalence Of Surgical Procedures Is Driving The Growth Of The Neuromuscular Blocking Drug Market. For further insights on the neuromuscular blocking drug market, request a sample here

What is the forecast market size or the forecast market value of the neuromuscular blocking drug market?

The neuromuscular blocking drug market size has increased by grown strongly in recent years. It will grow from $3.68 billion in 2023 to $3.87 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increased prevalence of conditions, increased awareness and training, increased healthcare spending, improved drug reversibility, and rise emphasis on patient safety. The neuromuscular blocking drug market size is expected to see strong growth in the next few years. It will grow to $4.75 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to regulatory approvals, growth in outpatient and day surgeries, the expansion of medical tourism and strategic alliances, the growing prevalence of musculoskeletal disorders, and the increasing prevalence of surgical procedures. Major trends in the forecast period include the development of non-sedative formulations, the development of new NMBDs, advances in personalized medicine, the development of combination therapies, and patient-centric drug development. For further insights on the neuromuscular blocking drug market, request a sample here

How is the neuromuscular blocking drug market segmented?

The neuromuscular blocking drug market is segmented
1) By Type: Non-Polarizing Agents, Depolarizing Agents
2) By Application: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others Applications
3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users For further insights on the neuromuscular blocking drug market, request a sample here

Which region has the largest share of the neuromuscular blocking drug market? What are the other regions covered in the report?

North America was the largest region in the neuromuscular blocking drug market in 2023. The regions covered in the neuromuscular blocking drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the neuromuscular blocking drug market, request a sample here.

Who are the major players in the neuromuscular blocking drug market?

What are the key trends in the neuromuscular blocking drug market?

Major trend in the neuromuscular blocking drug market - Advancements In Neuromuscular Blocking Drug Enhanced Market Growth. For further insights on the neuromuscular blocking drug market, request a sample here.

What are the major opportunities in the neuromuscular blocking drug market? What are the strategies for the neuromuscular blocking drug market?

For detailed insights on the major opportunities and strategies in the neuromuscular blocking drug market, request a sample here.

How does the neuromuscular blocking drug market relate to the overall economy and other similar markets?

For detailed insights on neuromuscular blocking drug market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the neuromuscular blocking drug industry?

For detailed insights on the mergers and acquisitions in the neuromuscular blocking drug industry, request a sample here.

What are the key dynamics influencing the neuromuscular blocking drug market growth? SWOT analysis of the neuromuscular blocking drug market.

For detailed insights on the key dynamics influencing the neuromuscular blocking drug market growth and SWOT analysis of the neuromuscular blocking drug industry, request a sample here.